<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="1" humanitarian="0" iati-activities:version="2.03" xml:lang="EN" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>SE-0-SE-29-2017-05543-282-12262</iati-identifier>
  <reporting-org ref="SE-0" secondary-reporter="0" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="SV">Riktad bek&#xE4;mpning mot v&#xE4;rds&#xF6;kande malariamyggor genom att utnyttja ett trick utvecklat av deras parasiter</narrative>
   <narrative xml:lang="EN">Targeting host seeking malaria mosquitoes using a trick evolved by their parasites</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="EN">HMBPP, a metabolite of the malaria parasite, Plasmodium falciparum, significantly impacts host seeking and blood feeding of African malaria mosquitoes. HMBPP indirectly induces the release of a volatile organic compound blend from human blood that acts as a potent attractant. The discovery of HMBPP, and its effects, provides the qualities needed for the development of a targeted novel mosquito control agent. The overall purpose and aim of this research proposal is the development of a novel &#x201C;lure&#x201D; to be used for mass trapping of mosquitoes in regions affected by malaria. A specific aim is to confirm that the HMBPP-induced blend attracts wild African malaria mosquitoes. This will be done both in semi-field enclosures and under field conditions. Another aim is to investigate why malaria mosquitoes are attracted to gametocyte carrying patients, by analysing volatiles, exhaled and emitted, by patients in malaria endemic areas. Finally, I will investigate whether mosquitoes probe micro-vessel beds, where the male and female mature gametocytes are present, and thereby clarify if HMBPP production of gametocytes is the reason for the observed increased transmission rate in most endemic settings. The findings of the proposed research will increase our understanding of malaria parasite transmission by the development of a novel control tool to reduce parasite transmission success in affected communities.</narrative>
   <narrative xml:lang="SV">M&#xE4;nniskor som insjuknat i malaria &#xE4;r s&#xE4;rskilt attraktiva f&#xF6;r v&#xE4;rds&#xF6;kande malariamyggor. En anledning till detta &#xE4;r att malariapatienter avger mer av vissa doft&#xE4;mnen, ett trick som malariaparasiten utvecklat f&#xF6;r att &#xF6;ka sina m&#xF6;jligheter att spridas. I en tidigare studie har jag p&#xE5;visat att malariaparasiten avger en substans, HMBPP, som p&#xE5;verkar de r&#xF6;da blodkropparna att avge dessa flyktiga &#xE4;mnen. M&#xE5;let med detta projekt &#xE4;r att dra nytta av dessa dofter och deras f&#xF6;rm&#xE5;ga att kraftfullt locka till sig malariamyggor. Inom projektet kommer jag att utv&#xE4;rdera effekten av denna doft p&#xE5; fler arter av malariamyggor i (i) laboratorief&#xF6;rs&#xF6;k, (ii) storskaliga semif&#xE4;ltf&#xF6;rs&#xF6;k och (iii) f&#xE4;ltf&#xF6;rs&#xF6;k. M&#xE5;let med dessa f&#xF6;rs&#xF6;k &#xE4;r att succesivt optimera den avgivningshastighet och formulering a dofter som b&#xE4;st fungerar att attrahera de arter av malariamyggor som &#xE4;r mest f&#xF6;rekommande i malariautsatta regioner i &#xF6;stra Afrika. Inom projektet planerar jag &#xE4;ven att (iv) kvantifiera flyktiga doft&#xE4;mnen i utandningsluft och fr&#xE5;n hud hos patienter som &#xE4;r infekterade med malariaparasiten, s&#xE4;rskilt de som b&#xE4;r p&#xE5; gametocyter. Anledningen till detta &#xE4;r att &#xF6;ka f&#xF6;rst&#xE5;elsen f&#xF6;r hur malariaparasiten signalerar till myggorna. Av samma anledning &#xE4;mnar jag att (v) analysera hur myggor lokaliserar HMBPP och gametocyter genom huden hos malariainfekterade personer. Detta kommer att g&#xF6;ras genom &#xA0;ett s&#xE5; kallat ex vivo f&#xF6;rfarande. De sammanlagda resultaten fr&#xE5;n detta projekt kommer att f&#xE5; praktisk anv&#xE4;ndning genom utveckling av en metod som direkt riktar sig mot v&#xE4;rds&#xF6;kande myggor. Vidare komemr projektet att leda till en &#xF6;kad f&#xF6;rst&#xE5;else f&#xF6;r hur malariaparasiten kommunicerar med sin vektor. Sammantaget kan projektet p&#xE5; sikt leda till en reducerad malariaf&#xF6;rekomst i drabbade omr&#xE5;den, och d&#xE4;rmed den globala malariaspridningen.</narrative>
  </description>
  <participating-org ref="51000" role="4" type="80">
   <narrative xml:lang="EN">Stockholms universitet</narrative>
  </participating-org>
  <participating-org ref="SE-0" role="1" type="10">
   <narrative xml:lang="EN">Sweden</narrative>
  </participating-org>
  <participating-org ref="SE-29" role="3" type="10">
   <narrative xml:lang="EN">The Swedish Research Council</narrative>
  </participating-org>
  <activity-status code="3"></activity-status>
  <activity-date iso-date="2018-01-01" type="1"></activity-date>
  <activity-date iso-date="2018-01-01" type="3"></activity-date>
  <contact-info>
   <organisation>
    <narrative xml:lang="EN">The Swedish Research Council</narrative>
   </organisation>
   <telephone>+46 8 546 44 000</telephone>
   <email>vetenskapsradet@vr.se</email>
   <website>www.vr.se</website>
   <mailing-address>
    <narrative xml:lang="EN">Box 1035, 101 38 Stockholm, Sweden</narrative>
   </mailing-address>
  </contact-info>
  <recipient-country code="TZ" percentage="100">
   <narrative xml:lang="EN">Tanzania, United Republic of</narrative>
  </recipient-country>
  <sector code="122" percentage="100" vocabulary="2">
   <narrative xml:lang="EN">Basic Health</narrative>
  </sector>
  <sector code="12262" percentage="100" vocabulary="1">
   <narrative xml:lang="EN">Malaria control</narrative>
  </sector>
  <tag code="3.3" vocabulary="3">
   <narrative xml:lang="EN">3.3 - By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases.</narrative>
   <narrative xml:lang="SV">3.3 - Senast 2030 utrota epidemierna av aids, tuberkulos, malaria och f&#xF6;rsummade tropiska sjukdomar samt bek&#xE4;mpa hepatit, vattenburna sjukdomar och andra smittsamma sjukdomar.</narrative>
  </tag>
  <policy-marker code="5" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention on Biological Diversity</narrative>
  </policy-marker>
  <policy-marker code="8" significance="1" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Convention to Combat Desertification</narrative>
  </policy-marker>
  <policy-marker code="7" significance="1" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Adaptation</narrative>
  </policy-marker>
  <policy-marker code="6" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Aid Targeting the Objectives of the Framework Convention on Climate Change - Mitigation</narrative>
  </policy-marker>
  <policy-marker code="2" significance="2" vocabulary="1">
   <narrative xml:lang="EN">Aid to Environment</narrative>
  </policy-marker>
  <policy-marker code="11" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disability</narrative>
  </policy-marker>
  <policy-marker code="10" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Disaster Risk Reduction(DRR)</narrative>
  </policy-marker>
  <policy-marker code="1" significance="1" vocabulary="1">
   <narrative xml:lang="EN">Gender Equality</narrative>
  </policy-marker>
  <policy-marker code="3" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Participatory Development/Good Governance</narrative>
  </policy-marker>
  <policy-marker code="9" significance="1" vocabulary="1">
   <narrative xml:lang="EN">Reproductive, Maternal, Newborn and Child Health (RMNCH)</narrative>
  </policy-marker>
  <policy-marker code="4" significance="0" vocabulary="1">
   <narrative xml:lang="EN">Trade Development</narrative>
  </policy-marker>
  <collaboration-type code="1"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="D02" vocabulary="1"></default-aid-type>
  <default-tied-status code="4"></default-tied-status>
  <budget>
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-12-28"></period-end>
   <value currency="USD" value-date="2018-01-01">155343.8276719138</value>
  </budget>
  <budget>
   <period-start iso-date="2019-01-01"></period-start>
   <period-end iso-date="2019-12-28"></period-end>
   <value currency="USD" value-date="2019-01-01">142768.0072758807</value>
  </budget>
  <budget>
   <period-start iso-date="2020-01-01"></period-start>
   <period-end iso-date="2020-12-28"></period-end>
   <value currency="USD" value-date="2020-01-01">146584.5793022574</value>
  </budget>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2017-10-27"></transaction-date>
   <value currency="USD" value-date="2017-10-27">473850.4738504738</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-01-28"></transaction-date>
   <value currency="USD" value-date="2018-01-28">155343.8276719138</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-01-28"></transaction-date>
   <value currency="USD" value-date="2019-01-28">142768.0072758807</value>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2020-01-28"></transaction-date>
   <value currency="USD" value-date="2020-01-28">146584.5793022574</value>
  </transaction>
  <crs-add>
   <other-flags code="1" significance="1"></other-flags>
  </crs-add>
  <sida:contribution xmlns:sida="http://sida.se/ns/contribution#"></sida:contribution>
 </iati-activity>
</iati-activities>
